WHC is still in active development. Read this to understand our approach.
depiction of FXMWUTGUCAKGQL-UHFFFAOYSA-N.svg
tripsit

dob

Check on tripsit

psychonaut

DOB

Check on psychonaut

isomerdesign

DOB

Check on isomerdesign

druglab

DOB

Check on druglab

drugmap

Brolamfetamine

Check on drugmap

wiki

2,5-Dimethoxy-4-brom...

Check on wiki

Data

InChI: InChI=1S/C11H16BrNO2/c1-7(13)4-8-5-11(15-3)9(12)6-10(8)14-2/h5-7H,4,13H2,1-3H3

Synonyms: 4-Bromo-DMA,Brolanfetamina,NCGC00168267-01, 4-Bromo-2,5-dimethoxyphenylisopropylamine,(+-)-2,5-Dimethoxy-4-bromoamphetamine, DOB,4-Bromo-2,5-dimethoxyamphetamine,GTPL155,2-(4-Bromo-2,5-dimethoxy-phenyl)-1-methyl-ethylamine((S)-(+)-DOB),Brolamfetamine,UNII-67WJC4Y2QY,(+-)-4-Bromo-2,5-dimethoxy-alpha-methylphenethylamine, 1-(4-Bromo-2,5-dimethoxyphenyl)-2-aminopropane,(R,S)-1-(4-Bromo-2,5-dimethoxyphenyl)propan-2-ylazan,dl-2,5-Dimethoxy-4-bromoamphetamine, 1-(2,5-Dimethoxyphenyl-4-bromo)-2-aminopropane,PDSP2_001339, 64638-07-9,Q209241, 2,5-Dimethoxy-4-bromoamphetamine, 1-(4-bromo-2,5-dimethoxyphenyl)propan-2-amine,J275.083J, 4-Bromo-2,5-dimethoxyamphetamine,1-(4-bromo-2,5-dimethoxyphenyl)propan-2-amine,67WJC4Y2QY, DEA No. 7391,CHEMBL6607,(-)-2-(4-Bromo-2,5-dimethoxy-phenyl)-1-methyl-ethylamine,4-Bromo-2,5-dimethoxyphenylisopropylamine,2-(4-Bromo-2,5-dimethoxy-phenyl)-1-methyl-ethylamine(DOB),Benzeneethanamine, 4-bromo-2,5-dimethoxy-alpha-methyl-, (+-)-,BROLAMFETAMINE [INCB:GREEN LIST],2-(4-Bromo-2,5-dimethoxy-phenyl)-1-methyl-ethylamine((-)-DOB),DOB,(+)-2-(4-Bromo-2,5-dimethoxy-phenyl)-1-methyl-ethylamine,Brolamfetaminum,2-(4-Bromo-2,5-dimethoxy-phenyl)-1-methyl-ethylamine[R(-)DOB],Benzeneethanamine, 4-bromo-2,5-dimethoxy-alpha-methyl-,(+)2-(4-Bromo-2,5-dimethoxy-phenyl)-1-methyl-ethylamine,2-(4-Bromo-2,5-dimethoxy-phenyl)-1-methyl-ethylamine((R)-(-)-DOB), Brolamfetaminum,BDBM50005257,4-Bromo-2,5-dimethoxy-amphetamine,64638-07-9,Benzeneethanamine, 4-bromo-2,5-dimethoxy-.alpha.-methyl-,2-(4-Bromo-2,5-dimethoxy-phenyl)-1-methyl-ethylamine,Brolamfetaminum [Latin],DTXSID5050428,Brolamphetamine,BROLAMFETAMINE [MART.],Brolamfetamine [INN],Brolamfetamin,Benzeneethanamine,4-bromo-2,5-dimethoxy-.alpha.-methyl-(.+/-.)-,(-)2-(4-Bromo-2,5-dimethoxy-phenyl)-1-methyl-ethylamine,NCGC00168267-02,Brolanfetamina [Spanish],(+-)-1-(4-Bromo-2,5-dimethoxyphenyl)-2-aminopropane,DB01484,32156-26-6,(+-)2,5-Dimethoxy-4-bromoamphetamine, Benzeneethanamine, 4-bromo-2,5-dimethoxy-alpha-methyl-, DOB-4,SCHEMBL714339,Racemic DOB,BROMO-DMA,[3H](+)DOB, 4-Bromo-DMA,GTPL163, 32156-26-6,(+/-)-4-BROMO-2,5-DIMETHOXY-.ALPHA.-METHYLPHENETHYLAMINE, 2,5-Dimethoxy-(4-bromo)phenylisopropylamine,(RS)-brolamfetamine, 4-Bromo-2,5-dimethoxy-alpha-methylbenzeneethanamine,L000010, CHEMBL6607,(+/-)2-(4-Bromo-2,5-dimethoxy-phenyl)-1-methyl-ethylamine,BROLAMFETAMINE [INCB GREEN LIST],2,5-DIMETHOXY-4-BROMAMPHETAMIN,PDSP1_001355,2,5-Dimethoxy-4-bromoamphetamine,DEA No. 7391

Estimated data

Solubility: -2.26 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 90.3% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.